New York State Common Retirement Fund Exact Sciences Corp Transaction History

New York State Common Retirement Fund

  • $74.9 Billion
  • Q3 2025

A detailed history of New York State Common Retirement Fund transactions in Exact Sciences Corp stock. As of the latest transaction made, New York State Common Retirement Fund holds 94,729 shares of EXAS stock, worth $6.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
94,729
Previous 92,729 2.16%
Holding current value
$6.35 Million
Previous $4.93 Million 5.18%
% of portfolio
0.01%
Previous 0.01%

Shares

44 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025
BUY
$40.91 - $56.0 $81,820 - $112,000
2,000 Added 2.16%
94,729 $5.18 Million
Q1 2025

Oct 08, 2025
SELL
$43.04 - $58.51 $5.05 Million - $6.87 Million
-117,433 Reduced 55.88%
92,729 $4.01 Million
Q1 2025

May 01, 2025
SELL
$43.04 - $58.51 $5.05 Million - $6.87 Million
-117,433 Reduced 55.88%
92,729 $4.01 Million
Q4 2024

Oct 08, 2025
SELL
$49.33 - $71.97 $4.25 Million - $6.2 Million
-86,213 Reduced 29.09%
210,162 $11.8 Million
Q4 2024

Jan 31, 2025
SELL
$49.33 - $71.97 $4.25 Million - $6.2 Million
-86,213 Reduced 29.09%
210,162 $11.8 Million
Q3 2024

Oct 08, 2025
BUY
$42.43 - $70.83 $8.64 Million - $14.4 Million
203,646 Added 219.61%
296,375 $20.2 Million
Q3 2024

Oct 28, 2024
SELL
$42.43 - $70.83 $695,979 - $1.16 Million
-16,403 Reduced 5.24%
296,375 $20.2 Million
Q2 2024

Oct 08, 2025
BUY
$41.33 - $74.26 $9.09 Million - $16.3 Million
220,049 Added 237.3%
312,778 $13.2 Million
Q2 2024

Jul 31, 2024
BUY
$41.33 - $74.26 $774,400 - $1.39 Million
18,737 Added 6.37%
312,778 $13.2 Million
Q1 2024

Oct 08, 2025
BUY
$56.27 - $73.77 $11.3 Million - $14.9 Million
201,312 Added 217.1%
294,041 $20.3 Million
Q1 2024

May 07, 2024
SELL
$56.27 - $73.77 $1.49 Million - $1.96 Million
-26,566 Reduced 8.29%
294,041 $20.3 Million
Q4 2023

Oct 08, 2025
BUY
$59.06 - $75.72 $13.5 Million - $17.3 Million
227,878 Added 245.75%
320,607 $23.7 Million
Q4 2023

Feb 01, 2024
SELL
$59.06 - $75.72 $1.13 Million - $1.45 Million
-19,097 Reduced 5.62%
320,607 $23.7 Million
Q3 2023

Oct 08, 2025
BUY
$65.94 - $99.04 $16.3 Million - $24.5 Million
246,975 Added 266.34%
339,704 $23.2 Million
Q3 2023

Nov 07, 2023
SELL
$65.94 - $99.04 $3.89 Million - $5.85 Million
-59,061 Reduced 14.81%
339,704 $23.2 Million
Q2 2023

Oct 08, 2025
BUY
$62.68 - $95.05 $19.2 Million - $29.1 Million
306,036 Added 330.03%
398,765 $37.4 Million
Q2 2023

Aug 07, 2023
BUY
$62.68 - $95.05 $303,809 - $460,707
4,847 Added 1.23%
398,765 $37.4 Million
Q1 2023

Oct 08, 2025
SELL
$47.19 - $70.77 $5.32 Million - $7.98 Million
-112,776 Reduced 22.26%
393,918 $26.7 Million
Q1 2023

May 18, 2023
BUY
$47.19 - $70.77 $42,471 - $63,693
900 Added 0.23%
393,918 $26.7 Million
Q1 2023

May 02, 2023
SELL
$47.19 - $70.77 $5.36 Million - $8.04 Million
-113,676 Reduced 22.43%
393,018 $26.7 Million
Q4 2022

Oct 08, 2025
BUY
$30.35 - $53.15 $12.6 Million - $22 Million
413,965 Added 446.42%
506,694 $25.1 Million
Q4 2022

Jan 30, 2023
BUY
$30.35 - $53.15 $2.87 Million - $5.03 Million
94,549 Added 22.94%
506,694 $25.1 Million
Q3 2022

Nov 08, 2022
SELL
$31.97 - $49.37 $3.4 Million - $5.25 Million
-106,349 Reduced 20.51%
412,145 $13.4 Million
Q2 2022

Aug 04, 2022
SELL
$35.61 - $76.23 $6.96 Million - $14.9 Million
-195,517 Reduced 27.38%
518,494 $20.4 Million
Q1 2022

May 05, 2022
BUY
$57.56 - $82.54 $11.2 Million - $16 Million
194,280 Added 37.38%
714,011 $49.9 Million
Q4 2021

Feb 02, 2022
SELL
$72.5 - $100.68 $14.3 Million - $19.8 Million
-196,986 Reduced 27.48%
519,731 $40.5 Million
Q3 2021

Nov 02, 2021
BUY
$90.24 - $124.05 $890,217 - $1.22 Million
9,865 Added 1.4%
716,717 $68.4 Million
Q2 2021

Aug 02, 2021
BUY
$93.66 - $139.27 $8.29 Million - $12.3 Million
88,522 Added 14.32%
706,852 $87.9 Million
Q1 2021

May 11, 2021
BUY
$116.57 - $155.01 $8.95 Million - $11.9 Million
76,818 Added 14.19%
618,330 $81.5 Million
Q4 2020

Feb 08, 2021
SELL
$99.61 - $142.12 $496,555 - $708,468
-4,985 Reduced 0.91%
541,512 $71.7 Million
Q3 2020

Nov 05, 2020
SELL
$72.92 - $102.01 $4.97 Million - $6.96 Million
-68,204 Reduced 11.1%
546,497 $55.7 Million
Q2 2020

Aug 07, 2020
BUY
$55.75 - $92.75 $2.36 Million - $3.92 Million
42,257 Added 7.38%
614,701 $53.4 Million
Q1 2020

May 06, 2020
BUY
$37.9 - $104.44 $4.48 Million - $12.3 Million
118,224 Added 26.03%
572,444 $33.2 Million
Q4 2019

Feb 05, 2020
BUY
$77.66 - $99.74 $7 Million - $9 Million
90,187 Added 24.77%
454,220 $42 Million
Q3 2019

Nov 07, 2019
SELL
$90.37 - $122.49 $3 Million - $4.06 Million
-33,145 Reduced 8.35%
364,033 $32.9 Million
Q2 2019

Aug 09, 2019
SELL
$89.51 - $118.04 $9.56 Million - $12.6 Million
-106,825 Reduced 21.2%
397,178 $46.9 Million
Q1 2019

May 08, 2019
SELL
$61.98 - $96.5 $5.25 Million - $8.17 Million
-84,676 Reduced 14.38%
504,003 $43.7 Million
Q4 2018

Feb 08, 2019
SELL
$56.04 - $82.66 $80,921 - $119,361
-1,444 Reduced 0.24%
588,679 $37.1 Million
Q3 2018

Nov 07, 2018
BUY
$48.29 - $80.6 $3.95 Million - $6.59 Million
81,757 Added 16.08%
590,123 $46.6 Million
Q2 2018

Aug 10, 2018
BUY
$37.84 - $69.96 $12.9 Million - $23.8 Million
340,064 Added 202.06%
508,366 $30.4 Million
Q1 2018

May 10, 2018
SELL
$39.82 - $57.53 $113,128 - $163,442
-2,841 Reduced 1.66%
168,302 $6.79 Million
Q4 2017

Feb 13, 2018
SELL
$46.49 - $60.51 $1.89 Million - $2.46 Million
-40,676 Reduced 19.2%
171,143 $8.99 Million
Q3 2017

Nov 06, 2017
BUY
$37.05 - $47.12 $2.04 Million - $2.6 Million
55,078 Added 35.14%
211,819 $9.98 Million
Q2 2017

Aug 11, 2017
BUY
N/A
156,741
156,741 $5.54 Million

Others Institutions Holding EXAS

# of Institutions
670
Shares Held
164M
Call Options Held
2.2M
Put Options Held
1.69M
View Full List

About EXACT SCIENCES CORP

EXAS Quotes by TradingView
  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $11.9B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email